AstraZeneca COVID-19 vaccine linked to ‘very small’ increased risk of bleeding, study says

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

The first dose of AstraZeneca’s COVID-19 vaccine was associated with a “very small” increased risk of a rare autoimmune disorder involving low platelet count.

Kayla Rivas

Kayla Rivas

Leave a Replay

Sign up for our Newsletter

Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit